694 related articles for article (PubMed ID: 30864716)
21. Metabolic Checkpoints: Novel Avenues for Immunotherapy of Cancer.
Shevchenko I; Bazhin AV
Front Immunol; 2018; 9():1816. PubMed ID: 30131808
[TBL] [Abstract][Full Text] [Related]
22. Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy.
Yin Z; Bai L; Li W; Zeng T; Tian H; Cui J
J Exp Clin Cancer Res; 2019 Sep; 38(1):403. PubMed ID: 31519198
[TBL] [Abstract][Full Text] [Related]
23. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
Wang H; Franco F; Ho PC
Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
[TBL] [Abstract][Full Text] [Related]
24. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
Huang L; Xu H; Peng G
Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
[TBL] [Abstract][Full Text] [Related]
25. Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy.
Kouidhi S; Ben Ayed F; Benammar Elgaaied A
Front Immunol; 2018; 9():353. PubMed ID: 29527212
[TBL] [Abstract][Full Text] [Related]
26. Dysfunctional T cell metabolism in the tumor microenvironment.
Beckermann KE; Dudzinski SO; Rathmell JC
Cytokine Growth Factor Rev; 2017 Jun; 35():7-14. PubMed ID: 28456467
[TBL] [Abstract][Full Text] [Related]
27. Vascular Microenvironment, Tumor Immunity and Immunotherapy.
Lamplugh Z; Fan Y
Front Immunol; 2021; 12():811485. PubMed ID: 34987525
[TBL] [Abstract][Full Text] [Related]
28. Immunometabolism and Its Potential to Improve the Current Limitations of Immunotherapy.
Sheppard AD; Lysaght J
Methods Mol Biol; 2020; 2184():233-263. PubMed ID: 32808230
[TBL] [Abstract][Full Text] [Related]
29. The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy.
Lim AR; Rathmell WK; Rathmell JC
Elife; 2020 May; 9():. PubMed ID: 32367803
[TBL] [Abstract][Full Text] [Related]
30. Immunological Aspects of Cancer Cell Metabolism.
Ucche S; Hayakawa Y
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791327
[TBL] [Abstract][Full Text] [Related]
31. T cells and cancer - why do the killers become exhausted?
Brück O; Keränen M; Dufva O; Kreutzman A; Mustjoki S
Duodecim; 2016; 132(21):1984-92. PubMed ID: 29190050
[TBL] [Abstract][Full Text] [Related]
32. Targeting PPAR ligands as possible approaches for metabolic reprogramming of T cells in cancer immunotherapy.
Bahrambeigi S; Molaparast M; Sohrabi F; Seifi L; Faraji A; Fani S; Shafiei-Irannejad V
Immunol Lett; 2020 Apr; 220():32-37. PubMed ID: 31982460
[TBL] [Abstract][Full Text] [Related]
33. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
34. Immuno-oncology-101: overview of major concepts and translational perspectives.
Allard B; Aspeslagh S; Garaud S; Dupont FA; Solinas C; Kok M; Routy B; Sotiriou C; Stagg J; Buisseret L
Semin Cancer Biol; 2018 Oct; 52(Pt 2):1-11. PubMed ID: 29428479
[TBL] [Abstract][Full Text] [Related]
35. The Immune Consequences of Lactate in the Tumor Microenvironment.
Harmon C; O'Farrelly C; Robinson MW
Adv Exp Med Biol; 2020; 1259():113-124. PubMed ID: 32578174
[TBL] [Abstract][Full Text] [Related]
36. Metabolic adaptation of lymphocytes in immunity and disease.
Chapman NM; Chi H
Immunity; 2022 Jan; 55(1):14-30. PubMed ID: 35021054
[TBL] [Abstract][Full Text] [Related]
37. [Metabolic Competition in Tumor Microenvironment].
Eikawa S; Udono H
Gan To Kagaku Ryoho; 2017 Nov; 44(11):972-976. PubMed ID: 29138369
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.
Noman MZ; Hasmim M; Messai Y; Terry S; Kieda C; Janji B; Chouaib S
Am J Physiol Cell Physiol; 2015 Nov; 309(9):C569-79. PubMed ID: 26310815
[TBL] [Abstract][Full Text] [Related]
39. Targeting immunometabolism of neoplasms by interleukins: A promising immunotherapeutic strategy for cancer treatment.
Zhu Z; Parikh P; Zhao H; Givens NT; Beck DB; Willson CM; Bai Q; Wakefield MR; Fang Y
Cancer Lett; 2021 Oct; 518():94-101. PubMed ID: 34153401
[TBL] [Abstract][Full Text] [Related]
40. Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression.
Zhang Q; Lou Y; Bai XL; Liang TB
World J Gastroenterol; 2018 Aug; 24(31):3500-3512. PubMed ID: 30131656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
